{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:34:18Z","timestamp":1787499258682,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82203218"],"award-info":[{"award-number":["NSFC82203218"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021QH008"],"award-info":[{"award-number":["ZR2021QH008"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["flzh202116"],"award-info":[{"award-number":["flzh202116"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10208-y","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T16:39:46Z","timestamp":1693931986000},"page":"1948-1959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Value of [18F]AlF-NOTA-FAPI-04 PET\/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [18F]FDG PET\/CT"],"prefix":"10.1007","volume":"34","author":[{"given":"Kailin","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"10208_CR1","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1128\/AAC.00789-09","volume":"53","author":"SL Davis","year":"2009","unstructured":"Davis SL, Nuermberger EL, Um PK et al (2009) Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob Agents Chemother 53:4879\u20134884","journal-title":"Antimicrob Agents Chemother"},{"key":"10208_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1148\/radiology.216.1.r00jl19117","volume":"216","author":"JM Goo","year":"2000","unstructured":"Goo JM, Im JG, Do KH et al (2000) Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 216:117\u2013121","journal-title":"Radiology"},{"key":"10208_CR3","first-page":"540","volume":"44","author":"Y Demura","year":"2003","unstructured":"Demura Y, Tsuchida T, Ishizaki T et al (2003) 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 44:540\u2013548","journal-title":"J Nucl Med"},{"key":"10208_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1053\/snuc.2002.127291","volume":"32","author":"A Alavi","year":"2002","unstructured":"Alavi A, Gupta N, Alberini JL et al (2002) Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32:293\u2013321","journal-title":"Semin Nucl Med"},{"key":"10208_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40425-019-0505-4","volume":"7","author":"J de Sostoa","year":"2019","unstructured":"de Sostoa J, Fajardo CA, Moreno R, Ramos MD, Farrera-Sal M, Alemany R (2019) Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager. J Immunother Cancer 7:19","journal-title":"J Immunother Cancer"},{"key":"10208_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T et al (2019) (68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med 60:386\u2013392","journal-title":"J Nucl Med"},{"key":"10208_CR7","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R (2018) Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene 37:4343\u20134357","journal-title":"Oncogene"},{"key":"10208_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2967\/jnumed.120.244806","volume":"62","author":"A Altmann","year":"2021","unstructured":"Altmann A, Haberkorn U, Siveke J (2021) The latest developments in imaging of fibroblast activation protein. J Nucl Med 62:160\u2013167","journal-title":"J Nucl Med"},{"key":"10208_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W et al (2018) A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med 59:1423\u20131429","journal-title":"J Nucl Med"},{"key":"10208_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T et al (2019) (68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med 60:801\u2013805","journal-title":"J Nucl Med"},{"key":"10208_CR11","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J et al (2020) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820\u20131832","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","volume":"809","author":"C Egger","year":"2017","unstructured":"Egger C, Cannet C, Gerard C et al (2017) Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol 809:64\u201372","journal-title":"Eur J Pharmacol"},{"key":"10208_CR13","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1007\/s00259-022-05706-y","volume":"49","author":"M Li","year":"2022","unstructured":"Li M, Younis MH, Zhang Y, Cai W, Lan X (2022) Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond. Eur J Nucl Med Mol Imaging 49:2844\u20132868","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR14","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/ar1877","volume":"8","author":"JM Milner","year":"2006","unstructured":"Milner JM, Kevorkian L, Young DA et al (2006) Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther 8:R23","journal-title":"Arthritis Res Ther"},{"key":"10208_CR15","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar2080","volume":"8","author":"S Bauer","year":"2006","unstructured":"Bauer S, Jendro MC, Wadle A et al (2006) Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther 8:R171","journal-title":"Arthritis Res Ther"},{"key":"10208_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","volume":"87","author":"J Tillmanns","year":"2015","unstructured":"Tillmanns J, Hoffmann D, Habbaba Y et al (2015) Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol 87:194\u2013203","journal-title":"J Mol Cell Cardiol"},{"key":"10208_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.010628","volume":"13","author":"MB Heckmann","year":"2020","unstructured":"Heckmann MB, Reinhardt F, Finke D et al (2020) Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease. Circ Cardiovasc Imaging 13:e010628","journal-title":"Circ Cardiovasc Imaging"},{"key":"10208_CR18","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1038\/s41598-017-09790-1","volume":"7","author":"CK Nagaraju","year":"2017","unstructured":"Nagaraju CK, Dries E, Popovic N et al (2017) Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction. Sci Rep 7:10801","journal-title":"Sci Rep"},{"key":"10208_CR19","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","volume":"32","author":"CE Brokopp","year":"2011","unstructured":"Brokopp CE, Schoenauer R, Richards P et al (2011) Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J 32:2713\u20132722","journal-title":"Eur Heart J"},{"key":"10208_CR20","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1007\/s00259-020-04818-7","volume":"47","author":"L Zhao","year":"2020","unstructured":"Zhao L, Chen S, Lin L et al (2020) [(68)Ga]Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer. Eur J Nucl Med Mol Imaging 47:3188\u20133189","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR21","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s00259-019-04478-2","volume":"46","author":"Y Luo","year":"2019","unstructured":"Luo Y, Pan Q, Zhang W (2019) IgG4-related disease revealed by (68)Ga-FAPI and (18)F-FDG PET\/CT. Eur J Nucl Med Mol Imaging 46:2625\u20132626","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","volume":"48","author":"H Chen","year":"2021","unstructured":"Chen H, Zhao L, Ruan D et al (2021) Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [(18)F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging 48:73\u201386","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415\u2013427","journal-title":"N Engl J Med"},{"key":"10208_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/cid\/civ1212","volume":"62","author":"MS Abers","year":"2016","unstructured":"Abers MS, Sandvall BP, Sampath R et al (2016) Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis 62:957\u2013961","journal-title":"Clin Infect Dis"},{"key":"10208_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1148\/radiology.166.3.3340764","volume":"166","author":"M Burke","year":"1988","unstructured":"Burke M, Fraser R (1988) Obstructive pneumonitis: a pathologic and pathogenetic reappraisal. Radiology 166:699\u2013704","journal-title":"Radiology"},{"key":"10208_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/cid\/ciw368","volume":"63","author":"KV Rolston","year":"2016","unstructured":"Rolston KV (2016) Postobstructive pneumonia in cancer patients. Clin Infect Dis 63:707\u2013708","journal-title":"Clin Infect Dis"},{"key":"10208_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.21037\/atm.2019.05.26","volume":"7","author":"A Valvani","year":"2019","unstructured":"Valvani A, Martin A, Devarajan A, Chandy D (2019) Postobstructive pneumonia in lung cancer. Ann Transl Med 7:357","journal-title":"Ann Transl Med"},{"key":"10208_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.782231","volume":"8","author":"H Liu","year":"2021","unstructured":"Liu H, Yang X, Liu L, Lei L, Wang L, Chen Y (2021) Clinical significance of diffusely increased uptake of (68)Ga-FAPI in thyroid gland. Front Med (Lausanne) 8:782231","journal-title":"Front Med (Lausanne)"},{"key":"10208_CR29","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","volume":"49","author":"P Conen","year":"2022","unstructured":"Conen P, Pennetta F, Dendl K et al (2022) [(68) Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease. Eur J Nucl Med Mol Imaging 49:3365\u20133372","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR30","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2967\/jnumed.122.264069","volume":"63","author":"FM Glatting","year":"2022","unstructured":"Glatting FM, Hoppner J, Liew DP et al (2022) Repetitive early (68)Ga-FAPI PET acquisition comparing (68)Ga-FAPI-02, (68)Ga-FAPI-46, and (68)Ga-FAPI-74: methodologic and diagnostic implications for malignant, inflammatory\/reactive, and degenerative lesions. J Nucl Med 63:1844\u20131851","journal-title":"J Nucl Med"},{"key":"10208_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jcmg.2021.09.029","volume":"15","author":"V Dilsizian","year":"2022","unstructured":"Dilsizian V, Budde RPJ, Chen W, Mankad SV, Lindner JR, Nieman K (2022) Best practices for imaging cardiac device-related infections and endocarditis: a JACC: Cardiovascular Imaging expert panel statement. JACC Cardiovasc Imaging 15:891\u2013911","journal-title":"JACC Cardiovasc Imaging"},{"key":"10208_CR32","doi-asserted-by":"publisher","first-page":"E733","DOI":"10.1152\/ajpendo.2002.282.3.E733","volume":"282","author":"S Rogers","year":"2002","unstructured":"Rogers S, Macheda ML, Docherty SE et al (2002) Identification of a novel glucose transporter-like protein-GLUT-12. Am J Physiol Endocrinol Metab 282:E733-738","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10208_CR33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/00003072-200410000-00017","volume":"29","author":"L Shin","year":"2004","unstructured":"Shin L, Katz DS, Yung E (2004) Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med 29:654\u2013656","journal-title":"Clin Nucl Med"},{"key":"10208_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2967\/jnumed.121.261925","volume":"63","author":"M Rohrich","year":"2022","unstructured":"Rohrich M, Leitz D, Glatting FM et al (2022) Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study. J Nucl Med 63:127\u2013133","journal-title":"J Nucl Med"},{"key":"10208_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00330-019-06342-1","volume":"30","author":"EK Choi","year":"2020","unstructured":"Choi EK, Park HL, Yoo IR, Kim SJ, Kim YK (2020) The clinical value of F-18 FDG PET\/CT in differentiating malignant from benign lesions in pneumoconiosis patients. Eur Radiol 30:442\u2013451","journal-title":"Eur Radiol"},{"key":"10208_CR36","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jmri.25832","volume":"47","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Kishida Y, Seki S et al (2018) Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: comparison with diffusion-weighted imaging and FDG-PET\/CT. J Magn Reson Imaging 47:1013\u20131021","journal-title":"J Magn Reson Imaging"},{"key":"10208_CR37","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","volume":"48","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J et al (2021) Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging 48:4377\u20134385","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10208_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.semnuclmed.2017.02.009","volume":"47","author":"RV Parghane","year":"2017","unstructured":"Parghane RV, Basu S (2017) Dual\u2013time point 18 F-FDG-PET and PET\/CT for differentiating benign from malignant musculoskeletal lesions: opportunities and limitations. Semin Nucl Med 47:373\u2013391","journal-title":"Semin Nucl Med"},{"key":"10208_CR39","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00330-019-06463-7","volume":"30","author":"M Nakajo","year":"2020","unstructured":"Nakajo M, Jinguji M, Aoki M, Tani A, Sato M, Yoshiura T (2020) The clinical value of texture analysis of dual-time-point (18)F-FDG-PET\/CT imaging to differentiate between (18)F-FDG-avid benign and malignant pulmonary lesions. Eur Radiol 30:1759\u20131769","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10208-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T16:10:52Z","timestamp":1708359052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10208-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["10208"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10208-y","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Yuchun Wei.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the institutional review board due to the retrospective and observational nature of the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional review board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}